A.O.SS Antonio Biagio e Cesare Arrigo Alessandria
- Address
- Via Venezia, 16 - 15121, 16121 Alessandria, Italy
A.O.SS Antonio Biagio e Cesare Arrigo Alessandria - Oncology and Hematology Research Center
A.O.SS Antonio Biagio e Cesare Arrigo Alessandria is a comprehensive medical research facility with particular expertise in oncology, hematology, and critical care medicine. The center conducts advanced clinical trials investigating novel therapeutic approaches for complex malignancies and hematologic disorders, with a focus on precision medicine and patient-centered care strategies.
- Primary central nervous system lymphoma treatment optimization and autologous stem cell transplantation
- Malignant pleural mesothelioma immunotherapy following surgical intervention
- Myelodysplastic syndromes and chronic lymphocytic leukemia with associated complications
- Cardiovascular event prevention in critical care and atrial fibrillation management
The research center demonstrates significant commitment to evaluating targeted biological therapies including atezolizumab for mesothelioma and ibrutinib for autoimmune complications in CLL patients. Their portfolio also extends to luspatercept therapy for transfusion-dependent anemia in myelodysplastic syndromes with del5q mutations. Additionally, the institution participates in critical care research addressing hemodynamic stability during intubation and anticoagulation strategies for stress-induced atrial fibrillation, reflecting their multidisciplinary approach to complex clinical challenges.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1Associazione Qol-One1active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in A.O.SS Antonio Biagio e Cesare Arrigo Alessandria
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy of Ibrutinib in Treating Autoimmune Hemolytic Anemia in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or CLL-like MBL | Fondazione Gimema Franco Mandelli Onlus | Phase II | Recruiting | Nov 2023 | — |
IMP list
lock Showing 1 of 14 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Apixaban | 1 | Unknown | 2024-01-29 | 2024-01-29 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.